What is Versigent 's change in accrued liabilities?

Versigent (VGNT) reported change in accrued liabilities of $56M in Q1 2026.

What does change in accrued liabilities mean?

Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.

Versigent VGNT Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Piper SandlerPIPR

-$410.07M-16.7%

RepligenRGEN

-$12.66M-800%

Dave, Inc.DAVE

-$151K+96.6%

InnodataINOD

$4.93M+2,081%

Enliven TherapeuticsELVN

-$4.47M-79.0%

Sphere EntertainmentSPHR

$8.72M-68.1%

Other financials

Income statement

See full

Revenue$2.2B+9.3%

Gross profit$244.0M-2.0%

Operating income$74.0M-39.8%

Net income$78.0M-17.9%

Balance sheet

See full

Cash & equivalents$282.0M—

Total debt$2.4B—

Total equity-$48.0M-103%

Total assets$4.9B—

Cash flow

See full

Operating cash flow$36.0M-10.0%

CapEx$66.0M+78.4%

Free cash flow-$30.0M-1,100%

Valuation

See full

Market cap$3.03B—

Returns & leverage

See full

Debt / equity0.2×—

Current ratio1.4×—

Where this comes from

Reported directly by Versigent in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.

The official record: Versigent ’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Versigent 's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Versigent 's change in accrued liabilities?: Versigent (VGNT) reported change in accrued liabilities of $56M in Q1 2026.
What does change in accrued liabilities mean?: Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.